Context-specific regulation of cell survival by a miRNA-controlled BIM rheostat
Knockout of the ubiquitously expressed miRNA-17∼92 cluster in mice produces a lethal developmental lung defect, skeletal abnormalities, and blocked B lymphopoiesis. A shared target of miR-17∼92 miRNAs is the pro-apoptotic protein BIM, central to life-death decisions in mammalian cells. To clarify th...
Saved in:
Published in | Genes & development Vol. 33; no. 23-24; pp. 1673 - 1687 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Cold Spring Harbor Laboratory Press
01.12.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Knockout of the ubiquitously expressed miRNA-17∼92 cluster in mice produces a lethal developmental lung defect, skeletal abnormalities, and blocked B lymphopoiesis. A shared target of miR-17∼92 miRNAs is the pro-apoptotic protein BIM, central to life-death decisions in mammalian cells. To clarify the contribution of miR-17∼92:Bim interactions to the complex miR-17∼92 knockout phenotype, we used a system of conditional mutagenesis of the nine
3' UTR miR-17∼92 seed matches. Blocking miR-17∼92:Bim interactions early in development phenocopied the lethal lung phenotype of miR-17∼92 ablation and generated a skeletal kinky tail. In the hematopoietic system, instead of causing the predicted B cell developmental block, it produced a selective inability of B cells to resist cellular stress; and prevented B and T cell hyperplasia caused by
haploinsufficiency. Thus, the interaction of miR-17∼92 with a single target is essential for life, and BIM regulation by miRNAs serves as a rheostat controlling cell survival in specific physiological contexts. |
---|---|
Bibliography: | Present addresses: 7Beijing IDMO Company Limited, Beijing 100000, China; 8Department of Pediatrics, Charité – University Hospital Berlin, Berlin 13353, Germany; 9Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; 10CRISPR Therapeutics, Cambridge, MA 02139, USA. |
ISSN: | 0890-9369 1549-5477 |
DOI: | 10.1101/gad.330134.119 |